Showing 151-160 of 1319 results for "".
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31273/Recent advancements and studies in neurology offer promising insights for clinical practice. A GlaxoSmithKline-sponsored trial compared the efficacy of lamotrigine versus topiramate in 192 epilepsy patients. Results demonstrated that lamotrigine outperformed topiramate on cognitive assessments such
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31332/In the realm of neurology, demonstrating patient health improvements necessitates robust qualitative measurements. Clinicians often rely on tools such as MRI comparisons, seizure frequency assessments, and evaluations of Parkinson’s “off” times to establish a baseline against which future treatments
- Will You Be the Last Physician on Your Block to Offer Botox?https://practicalneurology.com/columns/practice-management/will-you-be-the-last-physician-on-your-block-to-offer-botox/31384/Botox’s Expanding Role in Neurology: A Future for Headache ManagementBotox, traditionally renowned for its cosmetic applications, is increasingly becoming integral to neurological practices, particularly in headache and migraine management. As of October 2005, Practical Neurology highlighted Botox’s
- Intervention Can't Be Justified Without More Precise Patient Selectionhttps://practicalneurology.com/columns/practice-management/intervention-cant-be-justified-without-more-precise-patient-selection/31408/Carotid stenosis management remains a debated topic in neurology, particularly concerning asymptomatic carotid stenosis (ACS). The number needed to treat (NNT), as introduced by Laupacis et al., serves as a crucial metric in determining the effectiveness and cost-efficiency of interventions. For pat
Identification, Management, and Prevention of Polypharmacy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/identification-management-and-prevention-of-polypharmacy-in-multiple-sclerosis/32088/Rational prescription practices in multiple sclerosis treatment are key to the prevention and mitigation of polypharmacy.Expanding the Scope of Neurology: An Interview with Ralph L. Sacco, MD
https://practicalneurology.com/columns/practice-management/expanding-the-scope-of-neurology-an-interview-with-ralph-l-sacco-md/30358/New AAN President sees collaboration and wellness as integral to the future of the specialty.Proposed Hospital Standards for Parkinson Disease Care Aim to Avoid Preventable Harm
https://practicalneurology.com/programs/practical-neurology/proposed-hospital-standards-for-parkinson-disease-care-aim-to-avoid-preventable-harm/35438/Preventable harm is a serious concern for patients with Parkinson disease who receive care in the hospital setting, even when admitted for reasons other than their diagnosis. Peter Pronovost, MD, PhD, FCCM, Chief Quality and Transformation Officer at University Hospitals Cleveland Medical Center, ClNeuromuscular Notes: Genetic Testing for Neuromuscular Diseases
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-genetic-testing-for-neuromuscular-diseases/32181/This review presents a discussion on best practices for the clinical workup of suspected genetic neuromuscular diseases and provides an overview of how emerging technologies may aid diagnosis in the future.The Belly and the Brain: Weight Management and Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-belly-and-the-brain-weight-management-and-headache/39225/Jennifer Williams McVige, MD, Director of the DENT Concussion Institute and Attending Neurologist at the DENT Neurologic Institute, Buffalo, NY, discusses the clinical evidence linking weight management with the improvement of headache symptoms and outlines practical strategies—including diet and exA Treatment Within
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/a-treatment-within/30713/A small Phase I trial sees success using patients' own altered blood cells to fight immune responses in MS. Is this the future of MS therapy?